Total Payments
$244,313
2024 Payments
$683.42
Companies
25
Transactions
324
Medicare Patients
2,120
Medicare Billing
$192,601
Payment Breakdown by Category
Other$209,636 (85.8%)
Consulting$16,346 (6.7%)
Travel$9,512 (3.9%)
Food & Beverage$8,544 (3.5%)
Education$274.85 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $209,636 | 110 | 85.8% |
| Consulting Fee | $16,346 | 6 | 6.7% |
| Travel and Lodging | $9,512 | 60 | 3.9% |
| Food and Beverage | $8,544 | 138 | 3.5% |
| Education | $274.85 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $114,891 | 108 | $0 (2024) |
| Lilly USA, LLC | $44,167 | 40 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $40,697 | 58 | $0 (2020) |
| Amgen Inc. | $29,481 | 54 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $10,399 | 14 | $0 (2019) |
| Esperion Therapeutics, Inc. | $1,500 | 1 | $0 (2020) |
| Novo Nordisk Inc | $477.30 | 17 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $374.71 | 4 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $350.66 | 5 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $336.60 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $683.42 | 7 | Amgen Inc. ($201.07) |
| 2023 | $24,717 | 27 | Lilly USA, LLC ($12,813) |
| 2022 | $22,202 | 25 | Boehringer Ingelheim Pharmaceuticals, Inc. ($19,726) |
| 2021 | $39,835 | 36 | Boehringer Ingelheim Pharmaceuticals, Inc. ($35,313) |
| 2020 | $12,454 | 22 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,810) |
| 2019 | $64,005 | 91 | Boehringer Ingelheim Pharmaceuticals, Inc. ($21,056) |
| 2018 | $40,068 | 51 | Boehringer Ingelheim Pharmaceuticals, Inc. ($21,709) |
| 2017 | $40,347 | 65 | Novartis Pharmaceuticals Corporation ($26,769) |
All Payment Transactions
324 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $100.45 | General |
| Category: Cardiology | ||||||
| 06/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $100.62 | General |
| Category: Cardiology | ||||||
| 05/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $75.23 | General |
| Category: DIABETES | ||||||
| 03/21/2024 | Medtronic, Inc. | ENDURANT IIS (Device) | Food and Beverage | In-kind items and services | $180.45 | General |
| Category: Aortic Stent Grafts | ||||||
| 03/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $81.18 | General |
| Category: DIABETES | ||||||
| 01/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Obesity | ||||||
| 12/14/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 12/07/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PAH | ||||||
| 11/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: DIABETES | ||||||
| 11/02/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $137.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/26/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $312.50 | General |
| Category: Diabetes | ||||||
| 10/18/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $73.42 | General |
| Category: Obesity | ||||||
| 09/21/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $82.78 | General |
| 09/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: DIABETES | ||||||
| 08/30/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: DIABETES | ||||||
| 08/15/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $98.11 | General |
| Category: VTE | ||||||
| 08/09/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $52.18 | General |
| Category: DIABETES | ||||||
| 06/27/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Diabetes | ||||||
| 06/02/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Diabetes | ||||||
| 05/26/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Diabetes | ||||||
| 05/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: DIABETES | ||||||
| 05/18/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Diabetes | ||||||
| 05/18/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Diabetes | ||||||
| 05/17/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 367 | 515 | $356,651 | $35,425 |
| 2022 | 7 | 333 | 442 | $270,162 | $33,334 |
| 2021 | 8 | 486 | 740 | $292,064 | $58,057 |
| 2020 | 17 | 934 | 1,436 | $565,453 | $65,784 |
Total Patients
2,120
Total Services
3,133
Medicare Billing
$192,601
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 74 | 166 | $38,717 | $9,900 | 25.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 51 | 51 | $32,311 | $6,727 | 20.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 117 | 117 | $137,995 | $6,013 | 4.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 56 | $18,736 | $5,016 | 26.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 31 | 31 | $100,111 | $3,826 | 3.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 25 | 25 | $10,205 | $2,189 | 21.4% |
| Q9956 | Injection, octafluoropropane microspheres, per ml | Office | 2023 | 15 | 45 | $5,094 | $1,292 | 25.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 24 | 24 | $13,482 | $461.76 | 3.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 71 | 72 | $44,352 | $9,620 | 21.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 79 | 156 | $35,124 | $8,246 | 23.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 67 | $21,700 | $5,108 | 23.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 45 | 45 | $17,781 | $3,431 | 19.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 60 | 60 | $69,540 | $3,268 | 4.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 19 | 19 | $62,991 | $2,578 | 4.1% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2022 | 11 | 11 | $12,098 | $849.82 | 7.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 12 | 12 | $6,576 | $234.60 | 3.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 119 | 120 | $72,372 | $17,584 | 24.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 145 | 301 | $65,305 | $16,531 | 25.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 68 | 161 | $50,906 | $12,819 | 25.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 65 | 65 | $25,270 | $5,333 | 21.1% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 44 | 44 | $50,112 | $2,268 | 4.5% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2021 | 14 | 18 | $17,844 | $1,526 | 8.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 19 | 19 | $4,939 | $1,054 | 21.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 12 | 12 | $5,316 | $941.90 | 17.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 109 | 109 | $64,528 | $16,096 | 24.9% |
About Dr. David Murdock, MD
Dr. David Murdock, MD is a Cardiovascular Disease healthcare provider based in Wausau, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1942200910.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Murdock, MD has received a total of $244,313 in payments from pharmaceutical and medical device companies, with $683.42 received in 2024. These payments were reported across 324 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($209,636).
As a Medicare-enrolled provider, Murdock has provided services to 2,120 Medicare beneficiaries, totaling 3,133 services with total Medicare billing of $192,601. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Wausau, WI
- Active Since 07/29/2005
- Last Updated 01/17/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1942200910
Products in Payments
- JARDIANCE (Drug) $159,016
- ENTRESTO (Drug) $40,697
- Repatha (Biological) $29,454
- PRALUENT (Biological) $10,603
- NEXLIZET (Drug) $1,500
- XARELTO (Drug) $275.00
- FARXIGA (Drug) $267.88
- Adempas (Drug) $249.71
- VYNDAQEL (Drug) $226.54
- ENDURANT IIS (Device) $180.45
- PRALUENT ALIROCUMAB INJECTION (Biological) $132.76
- Kerendia (Drug) $125.00
- TYVASO (Drug) $125.00
- UPTRAVI (Drug) $125.00
- CARDIOMEMS (Device) $115.81
- Wegovy (Drug) $110.91
- ELIQUIS (Drug) $100.00
- PRALUENT (Drug) $99.69
- FLOWTRIEVER CATHETER, S (Device) $98.11
- Ozempic (Drug) $94.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Wausau
Dr. Mark Hoffmann, Md, MD
Cardiovascular Disease — Payments: $56,629
Cardiovascular Disease $56,629
Ronnie Ortiz, Md, MD
Cardiovascular Disease — Payments: $33,551
Cardiovascular Disease $33,551
Dr. Daniel Krause, Do, DO
Cardiovascular Disease — Payments: $3,351
Cardiovascular Disease $3,351
Dr. Samer Jabbour, Md, MD
Cardiovascular Disease — Payments: $1,137
Cardiovascular Disease $1,137
Dr. Paul Luetmer, Md, MD
Cardiovascular Disease — Payments: $926.48
Cardiovascular Disease $926.48
Dr. Timothy Logemann, Md, MD
Cardiovascular Disease — Payments: $870.68
Cardiovascular Disease $870.68